Could pregnancy checkups also screen for cancer genes?

NCT ID NCT07052266

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study explores whether offering genetic testing for inherited cancer risk (like BRCA1/2) during routine pregnancy or fertility care is practical and acceptable to patients. Researchers will enroll 550 people receiving prenatal or preconception care at Weill Cornell Medicine. The goal is to see how many complete both standard prenatal genetic screening and the optional cancer risk screening, and to understand if this approach could help catch cancer risks earlier, especially in underserved groups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

MyRisk Hereditary Cancer Test (genetic screening)

What this could lead to

If successful, this could show that offering cancer genetic testing during pregnancy or fertility care is practical and welcomed, potentially leading to earlier cancer detection and prevention in a broader population.

What could go wrong

This is an early feasibility study, not a treatment trial. It measures interest and completion rates, not health outcomes. Results may not apply to all populations or settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEREDITARY CANCER SYNDROMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hereditary neoplastic syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • NewYork-Presbyterian Weill Cornell Medicine

    NOT_YET_RECRUITING

    Brooklyn, New York, 11215, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • NewYork-Presbyterian Weill Cornell Medicine Queens

    RECRUITING

    Queens, New York, 11355, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Reproductive Medicine

    RECRUITING

    Brooklyn, New York, 11201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Reproductive Medicine

    RECRUITING

    New York, New York, 10021, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Weill Cornell Medicine

    RECRUITING

    New York, New York, 10065, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••